Mr. Van Hollen (for himself and Mr. Braley of Iowa) introduced the following bill; which was referred to the Committee on Energy and Commerce
Bill Number
H.R. 4384
Bill Version
Introduced in House (IH)
Full Title
To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.